By Neil Kaplowitz, Laurie D. DeLeve
Epidemiological stories have came across that medications at the moment are the most typical explanation for liver failure within the usa, and the previous decade has noticeable an explosion of recent details about the immunology, toxicology, and pharmacology of drug-induced liver disorder. This expertly written moment version offers an in-depth dialogue of the new advancements in drug-induced hepatotoxicity, masking mechanisms, histopathology, administration, danger elements, and styles of drug and toxin-induced liver affliction.
Read Online or Download Drug-Induced Liver Disease PDF
Best gastroenterology books
It is a 3-in-1 reference ebook. It offers an entire clinical dictionary overlaying 1000's of phrases and expressions on the subject of acanthosis nigricans. It additionally provides huge lists of bibliographic citations. eventually, it offers info to clients on find out how to replace their wisdom utilizing numerous web assets.
Atlas illustrating the surgeries used to regard gastrointestinal tract ailment, for practitioners. Covers surgical anatomy, the preoperative and intraoperative prognosis, and surgical indication. Translation. DNLM: Gastrointestinal procedure - surgical procedure - atlases.
This new identify within the award-winning Lecture Notes sequence offers a clinically-oriented method of the examine of gastroenterology and hepatology, overlaying either the scientific and surgical features of gastrointestinal perform. It explores organ-specific problems, scientific fundamentals, and gastrointestinal emergencies, including an in depth self-assessment part.
- Le ventre, notre deuxième cerveau
- Managing Failed Anti-Reflux Therapy
- Colon, Rectum and Anus: Anatomic, Physiologic and Diagnostic Bases for Disease Management
- Liver Transplantation: Update of Concepts and Practice, An Issue of Clinics in Liver Disease, 1e
- Diet-microbe interactions in the gut : effects on human health and disease
Additional resources for Drug-Induced Liver Disease
Drug-protein adducts: an industry perspective on minimizing the potential for drug bioactivation in drug discovery and development. Chem Res Toxicol 2004; 17(1):3–16. 63. Qiu Y, Benet LZ, Burlingame AL. Identiﬁcation of the hepatic protein targets of reactive metabolites of acetaminophenin in vivo in mice using two-dimensional gel electrophoresis and mass spectrometry. J Biol Chem 1998; 273(28):17940–53. 64. Nelson SD, Dahlin DC, Rauckman EJ, et al. Peroxidase-mediated formation of reactive metabolites of acetaminophen.
Iyer R, Coles B, Raney KD, et al. DNA adduction by the potent carcinogen aﬂatoxin B1: mechanistic studies. J Am Chem Soc 1994; 116(5):1603–9. 68. Johnson WW, Guengerich FP. Reaction of aﬂatoxin B1 exo-8,9-epoxide with DNA: kinetic analysis of covalent binding and DNA-induced hydrolysis. Proc Natl Acad Sci USA 1997; 94(12):6121–5. 69. Johnson WW, Ueng Y-F, Mannervik B, et al. Conjugation of highly reactive aﬂatoxin B1 8,9-exoepoxide catalyzed by rat and human glutathione transferases: estimation of kinetic parameters.
This aspect can be done without radiolabeled material. Quantitation of in vivo (animal) results is done subsequently, with radiolabeled drug. A rough decision cutoff value of 50 pmol adduct/mg protein has been proposed (62), but obviously this value would be a function of dose, time, etc. The overall plan in these strategies is to ﬁnd better and earlier biomarkers that can be used effectively in the development process and even in clinical trials and marketed drugs. A critical issue with candidates found in animals is extrapolation to humans.